adenocarcinoma

Authors and Affiliations:
AES Simões¹, DM Pereira¹, SE Gomes1, H Brito¹, T Carvalho², A French³, RE Castro¹, CJ Steer^4,5, SN Thibodeau³, CMP Rodrigues^*,1,6 and PM Borralho^*,1,6

¹ Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisbon 1649-003, Portugal;